Get the app!
Back to Trades

Goodrich Katherine

DirectorCIK 0002044770

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
4
Buy transactions
0
Sell transactions
1
Companies
1
Active
2026

Goodrich Katherine, Director, accounts for 4 disclosed filings worth $430.3K, all concentrated in Tarsus Pharmaceuticals, Inc. (TARS), active 2026. The record is heavily weighted toward selling, with $0 in purchases against $183.4K in sales. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

4 loaded
Jun 29TARS
Tarsus Pharmaceuticals, Inc.
Goodrich KatherineDirectorAward$246.9K
Jun 17TARS
Tarsus Pharmaceuticals, Inc.
Goodrich KatherineDirectorSell$183.4K
Jun 16TARS
Tarsus Pharmaceuticals, Inc.
Goodrich KatherineDirectorExercise$0
Jan 14TARS
Tarsus Pharmaceuticals, Inc.
Goodrich KatherineDirectorExercise$0

4 filings